Life Sciences & Biotech

The Life Sciences & Biotech content community explores a wide range of topic areas including drug discovery and development, regulation and compliance, innovation in digital pharma, clinical trials and virtual trials, translating research, commercialization and capital raising, manufacturing quality and compliance, data integrity and GAMP, COVID-19 market scenarios and much more! It offers a range of perspectives from the Asia-Pacific region, Australia and around the world.

Via a mix of engaging formats, we offer a wealth of unique, content particularly relating to the content raised in our flagship conferences ISPE Singapore Affiliate Conference & Exhibition, Bio Connections Australia, Pharmacon Asia and BDP China.

Latest videos

Insights

   

Vaccine development – what have we learned from COVID-19?

  • August 18, 2020

From the moment a pandemic is declared, every day, week and month that passes without a vaccine is significant. Globally, Coronavirus...

   

How AUM Biosciences is improving drug availability and affordability worldwide

  • June 25, 2019

An award winning biotech startup, AUM Biosciences, is addressing the low returns on R&D investment that currently exist in oncology drug...

Audience

Life Sciences + BIo - Breakdown

  • Pharma / Bio Tech - 50%
  • Research / Universities - 16%
  • Regulators / Govt Agencies - 15%
  • Med Tech / Tech Solution Providers - 10%
  • CDMOs / CROs / CMOs - 6%
  • Other - 3%

Associated Events

Bio Connections Australia

12 August 2021 | Melbourne

View Event

ISPE

25-27 August 2021 | Suntec Singapore & Online

View Event

8th Annual PharmaCon Asia

5-6 October 2021 | One Farrer Hotel, Singapore

View Event

Biopharma Development and Production Week

15 – 17 November 2021 | Hilton Shanghai

View Event

Top